Vera Therapeutics

VERANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.468 B

$34.25 +0.73%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

-$299.6M

Loss-making

Shares outstanding

72,063,335

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#88Mineralys TherapeuticsMLYS$2.50B
#89Supernus PharmaceuticalsSUPN$2.49B
#90Vera TherapeuticsVERA$2.47B
#91Harmony BiosciencesHRMY$2.45B
#92Viridian TherapeuticsVRDN$2.44B

What if Vera Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.3T

$420,103.43

Per share 12,266× higher

Bitcoin $1.72T

$23,865.17

Per share 697× higher

Nvidia $5.48T

$76,042.25

Per share 2,220× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Vera Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.